Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 12, 2010, Pages 1215-1224

  Torres, L C ^a   Sugayama, S M M ^a   Arslanian, C ^a   Sales, M M ^a   Carneiro Sampaio, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibody response; B lymphocyte; High IgM levels; Rubinstein Taybi syndrome

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; POLYSACCHARIDE; PROTEIN P300;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE SUBPOPULATION; MALE; PRESCHOOL CHILD; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; RUBINSTEIN SYNDROME; SCHOOL CHILD;

BACTERIA (MICROORGANISMS);

EID: 78650623883     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500119     Document Type: Article

References (30)

1. Rubinstein JH. Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957-1988. Am J Med Genet Suppl 1990; 6: 3-16.
2. Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2002; 30: 52-55.
3. Hennekam RC, Stevens CA, Van de Kamp JJ. Etiology and recurrence risk in Rubinstein-Taybi syndrome. Am J Med Genet Suppl 1990; 6: 56-64.
4. Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet 2006; 14: 981-985.
5. Stevens CA, Carey JC, Blackburn BL. Rubinstein-Taybi syndrome: a natural history study. Am J Med Genet Suppl 1990; 6: 30-37.
6. Lacombe D, Saura R, Taine L, Battin J. Confirmation of assignment of a locus for Rubinstein-Taybi syndrome gene to 16p13.3. Am J Med Genet 1992; 44: 126-128.
7. Bartsch O, Schmidt S, Richter M, Morlot S, Seemanova E, Wiebe G, et al. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 2005; 117: 485-493.
8. Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 2005; 76: 572-580.
9. Foley P, Bunyan D, Stratton J, Dillon M, Lynch SA. Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am J Med Genet A 2009; 149A: 997-1000.
10. Rivas F, Fragoso R, Ramos-Zepeda R, Vaca G, Hernandez A, Gonzalez-Quiroga G, et al. Deficient cell immunity and mild intermittent hyperaminoacidemia in a patient with the Rubinstein-Taybi syndrome. Acta Paediatr Scand 1980; 69: 123-125.
11. Villella A, Bialostocky D, Lori E, Meyerson H, Hostoffer RW. Rubinstein-Taybi syndrome with humoral and cellular defects: a case report. Arch Dis Child 2000; 83: 360-361.
12. Ming JE, Stiehm ER, Graham JM Jr. Immunodeficiency as a component of recognizable syndromes. Am J Med Genet 1996; 66: 378-398.
13. Freitas NM, Imbronito AV, La Scala CS, Lotufo RF, Pustiglioni FE. Periodontal disease in a Rubinstein-Taybi syndrome patient: case report. Int J Paediatr Dent 2006; 16: 292-296.
14. Torres LC, de Lourdes Lopes CM, Delboni TP, Okay TS, Carneiro-Sampaio M, Sugayama S. Rubinstein-Taybi syndrome: a female patient with a de novo reciprocal translocation t(2; 16)(q36.3; p13.3) and dysgranulopoiesis. Clinics References 2010; 65: 107-109.
15. Naspitz CK, Solé D, Carneiro-Sampaio MM, Gonzalez CH. Serum levels of IgG, IgM, and IgA in healthy Brazilian children. J Pediatr 1982; 62: 121-126.
16. Sorensen RU, Hidalgo H, Moore C, Leiva LE. Post-immunization pneumococcal antibody titers and IgG subclasses. Pediatr Pulmonol 1996; 22: 167-173.
17. Sorensen RU, Leiva LE, Javier FC III, Sacerdote DM, Bradford N, Butler B, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 1998; 102: 215-221.
18. Xu W, Fukuyama T, Ney PA, Wang D, Rehg J, Boyd K, et al. Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood 2006; 107: 4407-4416.
19. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998; 1: 661-671.
20. Parker D, Ferreri K, Nakajima T, LaMorte VJ, Evans R, Koerber SC, et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 1996; 16: 694-703.
21. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997; 94: 2927-2932.
22. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci U S A 2002; 99: 14789-14794.
23. Zhang CY, Wu YL, Boxer LM. Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. J Biol Chem 2002; 277: 48359-48365.
24. Naimi DR, Munoz J, Rubinstein J, Hostoffer RW Jr. Rubinstein- Taybi syndrome: an immune deficiency as a cause for recurrent infections. Allergy Asthma Proc 2006; 27: 281-284.
25. Carneiro-Sampaio M, Coutinho A. Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun 2007; 75: 1545-1555.
26. Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C, Leiden JM. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 1996; 379: 81-85.
27. Zhang F, Rincon M, Flavell RA, Aune TM. Defective Th function induced by a dominant-negative cAMP response element binding protein mutation is reversed by Bcl-2. J Immunol 2000; 165: 1762-1770.
28. Xiang H, Wang J, Boxer LM. Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. Mol Cell Biol 2006; 26: 8599-8606.
29. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 1996; 16: 5546-5556.
30. Arcinas M, Heckman CA, Mehew JW, Boxer LM. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. Cancer Res 2001; 61: 5202-5206